Dr. Krishnan Chakravarthy MD, PhD founded NanoAxis in 2008. As Chairman and CEO of NanoAxis, Dr. Chakravarthy is developing paradigm-shifting technology in the field of infectious diseases, orthopedics, and neurosciences. He holds a B.A. degree in Biology from the University of Chicago. He completed his joint MD, PhD program at the State University of New York at Buffalo School of Medicine and Biomedical Sciences. In addition, he has served as a contractor at the U.S. Centers for Disease Control and Prevention (CDC) where he researched host immunity to influenza virus as a way of developing novel therapeutic and vaccine strategies. At present Krishnan is an resident anesthesiologist in the Department of Anesthesiology and Critical Care Medicine at the prestigious Johns Hopkins Hospital in Baltimore, Maryland USA.

Dr. Chakravarthy’s innovative contributions to the field of nanomedicine has been recognized at a national level with prestigious honors and awards. He continues to publish papers in leading scientific journals, is an author on numerous patents, and is a guest speaker at both national and international conferences worldwide. As Founder and CEO, he intends to guide NanoAxis to becoming a global leader in nanomedicine technologies, placing NanoAxis at the cutting edge of medicine and nanotechnology.

Dr. Chakravarthy currently serves on the board of the Academy of Medical Ethics in Bio-Innovation, VietMD.net, Clinical Research Monitor, and is a affiliated faculty for the Johns Hopkins Institute of NanoBioTechnology (INBT).